A community perspective on the efficacy of malaria treatment options for children in Lundazi District, Zambia

Abstract
Summary In 1996, Zambia's Ministry of Health made sulfadoxine‐pyrimethamine (SP) available as a second‐line antimalarial. SP differs from chloroquine (CQ) in ways that might affect parents' acceptanc...